PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells

Carcinogenesis

Volumn 31, Issue 7, 2010, Pages 1211-1219

  Tian, Tao ^a   Nan, Ke Jun ^a   Wang, Shu Hong ^a   Liang, Xuan ^a   Lu, Chuang Xin ^a   Guo, Hui ^a   Wang, Wen Juan ^a   Ruan, Zhi Ping ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HEPG2; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; GENE OVEREXPRESSION; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CARCINOMA, HEPATOCELLULAR; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77954374206     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq085     Document Type: Article

References (40)

1. El-Serag,H.B. et al. (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-2576.
2. Fernández,M. et al. (2009) Angiogenesis in liver disease. J. Hepatol., 50, 604-620.
3. Hillen,F. et al. (2007) Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev., 26, 489-502.
4. Roskoski,R.Jr. (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit. Rev. Oncol. Hematol., 62, 179-213.
5. Schoenleber,S.J. et al. (2009) Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and metaanalysis. Br. J. Cancer, 100, 1385-1392.
6. Yao,Y.J. et al. (1999) PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene, 18, 3181-3185.
7. Bae,J.J. et al. (2007) Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients. Oncol. Rep., 18, 1007-1013.
8. Vinciguerra,M. et al. (2008) PTEN at the crossroad of metabolic diseases and cancer in the liver. Ann. Hepatol., 7, 192-199.
9. Li,L. et al. (2007) Why is PTEN an important tumor suppressor? J. Cell. Biochem., 102, 1368-1374.
10. Rossi,D.J. et al. (2006) Pten, tumorigenesis, and stem cell self-renewal. Cell, 125, 229-231.
11. Wu,Z. et al. (2007) The role of PTEN in prostate cancer cell tropism to the bone micro-environment. Carcinogenesis, 28, 1393-1400.
12. Lee,J.O. et al. (1999) Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell, 99, 323-334.
13. Cully,M. et al. (2006) Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer, 6, 184-192.
14. Salmena,L. et al. (2008) Tenets of PTEN tumor suppression. Cell, 133, 403-414.
15. Chalhoub,N. et al. (2009) PTEN and the PI3-kinase pathway in cancer. Annu. Rev. Pathol., 4, 127-150.
16. Raftopoulou,M. et al. (2004) Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science, 303, 1179-1181.
17. Leslie,N.R. et al. (2007) PtdIns(3,4,5)P-3-dependent and -independent roles for PTEN in the control of cell migration. Curr. Biol., 17, 115-125.
18. Freeman,D.J. et al. (2003) PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell, 3, 117-130.
19. Yin,Y. et al. (2008) PTEN: a new guardian of the genome. Oncogene, 27, 5443-5453.
20. Trotman,L.C. et al. (2007) Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell, 128, 141-156.
21. Shen,W.H. et al. (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell, 128, 157-170.
22. Eng,C. (2003) PTEN: one gene, many syndromes. Hum. Mutat., 22, 183-198.
23. Kang-Park,S. et al. (2003) PTEN modulates insulin-like growth factor II (IGF-II)-mediated signaling; the protein phosphatase activity of PTEN downregulates IGF-II expression in hepatoma cells. FEBS Lett., 545, 203-208.
24. Meng,F. et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-658.
25. Shin,S. et al. (2006) Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells., 24, 125-138.
26. Perri,S.R. et al. (2005) Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression. Cancer Res., 65, 8359-8365.
27. Schmittgen,T.D. et al. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc., 3, 1101-1108.
28. Weidner,N. et al. (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324, 1-8.
29. Lamalice,L. et al. (2007) Endothelial cell migration during angiogenesis. Circ. Res., 100, 782-794.
30. Carmeliet,P. (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology, 69 (suppl. 3), 4-10.
31. Olsson,A.K. et al. (2006) VEGF receptor signalling-in control of vascular function. Nat. Rev. Mol. Cell Biol., 7, 359-371.
32. Fang,J. et al. (2007) PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell. Signal., 19, 2487-2497.
33. Takei,Y. et al. (2008) Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice. Mol. Cancer Ther., 7, 704-711.
34. Pore,N. et al. (2006) Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol. Cancer Res., 4, 471-479.
35. Emerling,B.M. et al. (2008) PTEN regulates p300-dependent hypoxiainducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). Proc. Nat. Acad. Sci. USA, 105, 2622-2627.
36. Hasan,J. et al. (2004) Quantitative angiogenesis assays in vivo-a review. Angiogenesis, 7, 1-16.
37. Maynard,M.A. et al. (2007) The role of hypoxia-inducible factors in cancer. Cell. Mol. Life Sci., 64, 2170-2180.
38. Hirota,K. et al. (2006) Regulation of angiogenesis by hypoxia-inducible factor 1. Crit. Rev. Oncol. Hematol., 59, 15-26.
39. Weidemann,A. et al. (2008) Biology of HIF-1alpha. Cell Death Differ., 15, 621-627.
40. Kawamura,N. et al. (1999) PTEN/MMAC1 mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors. Jpn. J. Cancer Res., 90, 413-418.